Late-Breaking Abstracts Demonstrate Value of Persistence With Ruxolitinib Cream for Vitiligo
March 18th 2023Amid a packed roster of of late-breaking research at the American Academy of Dermatology 2023 Annual Meeting, investigators presented findings from long-term extensions of the Topical Ruxolitinib Evaluation in Vitiligo phase 3 studies.
Read More
Dermatology Data Can Direct Policy Priorities, but Gaps Reflect Inequities of Care
March 18th 2023Speakers at the American Academy of Dermatology 2023 Annual Meeting highlighted the potential of DataDerm to tell the story of dermatological care in the United States, but some also cautioned that the registry only reflects those who have access to care in the first place.
Read More
Patients With AD May Have Greater Risk of Certain Malignancies
March 17th 2023Investigators of this study noted the need for more data on risks of malignancies among patients who have atopic dermatitis (AD), with the chronic skin condition already having significant associations with nonmelanoma skin cancer, lymphoma, keratinocyte carcinoma, and pancreatic and kidney cancers.
Read More
Experts Herald “Year of the JAK Inhibitor” in Dermatology
March 17th 2023A symposium at the American Academy of Dermatology 2023 Annual Meeting convened speakers who presented current data on the use of Janus kinase (JAK) inhibitors in dermatology, including in atopic dermatitis and vitiligo.
Read More
Dr Kevan Herold on Living With T1D: “There's Nothing You Do Without Thinking About It”
March 17th 2023It's harder for younger children to deal with the complexities of managing type 1 diabetes (T1D), so a delayed diagnosis even by a few years is a big deal, said Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine.
Watch
AMCP 2023 Will Cover Biosimilars, Inflation Reduction Act, and Much More, Says Kimberly Westrich
March 16th 2023Kimberly Westrich, director of value and access strategy at AmerisourceBergen, previews AMCP 2023 and her preconference session about incorporating value framework assessments into coverage and reimbursement decision-making.
Watch
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
Read More
Trio of Scales Deemed Valid, Reliable for Use in Prurigo Nodularis
March 16th 2023The Skin Pain Numeric Rating Scale, Worst-Itch Numeric Rating Scale, and Dermatology Life Quality Index were evaluated for their content validity, fit-for-purpose, and psychometric and measurement properties among patients with the chronic skin disease being treated with dupilumab.
Read More
Co-occurring Diabetes and Tooth Loss Linked to Worse, Faster Cognitive Decline
March 15th 2023New research suggests older adults with both diabetes and edentulism are more likely to experience worse and faster cognitive decline compared with adults without either condition and adults older in age.
Read More
Racial, Ethnic, Socioeconomic Disparities Identified Among Patients With Cachexia at NSCLC Diagnosis
March 15th 2023A recent study identified disparities in cachexia incidence among patients with stage IV non–small cell lung cancer (NSCLC) across different racial, ethnic, and socioeconomic groups.
Read More